Sprint Bioscience AB (SPRINT) — Capital Reinvestment Ratio
Sprint Bioscience AB (SPRINT) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow (Skr115.84 Million) in capital expenditures (Skr65.00K). Check Sprint Bioscience AB (SPRINT) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sprint Bioscience AB Capital Reinvestment Ratio (2015–2025)
This chart tracks Sprint Bioscience AB's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see Sprint Bioscience AB cash flow conversion.
Annual Capital Reinvestment Ratio for Sprint Bioscience AB (2015–2025)
Year-by-year Capital Reinvestment Ratio for Sprint Bioscience AB from 2015 to 2025. See free cash flow generation of Sprint Bioscience AB to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | Skr83.53 Million | Skr94.00K | ▼ -99.0% |
| 2023 | 0.11x | Skr22.87 Million | Skr2.45 Million | ▼ -91.4% |
| 2016 | 1.25x | Skr7.93 Million | Skr9.91 Million | ▼ -83.2% |
| 2015 | 7.43x | Skr833.54K | Skr6.19 Million | — |